These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30894280)

  • 41. miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways.
    He Q; Ren X; Chen J; Li Y; Tang X; Wen X; Yang X; Zhang J; Wang Y; Ma J; Liu N
    Oncotarget; 2016 Jan; 7(3):3047-58. PubMed ID: 26655091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metallopanstimulin-1 regulates invasion and migration of gastric cancer cells partially through integrin β4.
    Yang ZY; Jiang H; Qu Y; Wei M; Yan M; Zhu ZG; Liu BY; Chen GQ; Wu YL; Gu QL
    Carcinogenesis; 2013 Dec; 34(12):2851-60. PubMed ID: 23803695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
    Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
    Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic cancer cells.
    Gao Y; Hou J; Fei X; Ren L; Lu R; Liu P; Liu S; Zhu C; Wang X; Pan Y
    Cell Signal; 2024 Aug; 120():111227. PubMed ID: 38744388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PLS3 predicts poor prognosis in pancreatic cancer and promotes cancer cell proliferation via PI3K/AKT signaling.
    Xin Z; Li D; Mao F; Du Y; Wang X; Xu P; Li Z; Qian J; Yao J
    J Cell Physiol; 2020 Nov; 235(11):8416-8423. PubMed ID: 32239705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of different iodine levels on the DNA methylation of PRKAA2, ITGA6, THEM4 and PRL genes in PI3K-AKT signaling pathway and population-based validation from autoimmune thyroiditis patients.
    Ren B; Wan S; Wu H; Qu M; Chen Y; Liu L; Jin M; Zhou Z; Shen H
    Eur J Nutr; 2022 Oct; 61(7):3571-3583. PubMed ID: 35622138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
    He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
    Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Girdin regulates the proliferation and apoptosis of pancreatic cancer cells via the PI3K/Akt signalling pathway.
    Wang S; Lei Y; Cai Z; Ye X; Li L; Luo X; Yu C
    Oncol Rep; 2018 Aug; 40(2):599-608. PubMed ID: 29901184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
    Yu ST; Zhong Q; Chen RH; Han P; Li SB; Zhang H; Yuan L; Xia TL; Zeng MS; Huang XM
    Cell Death Dis; 2018 Mar; 9(3):371. PubMed ID: 29515111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K/AKT pathway in gallbladder carcinoma.
    Jin YP; Hu YP; Wu XS; Wu YS; Ye YY; Li HF; Liu YC; Jiang L; Liu FT; Zhang YJ; Hao YJ; Liu XY; Liu YB
    Cell Death Dis; 2018 Feb; 9(2):182. PubMed ID: 29416013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axis.
    Liu QG; Li YJ; Yao L
    Pancreatology; 2018 Sep; 18(6):678-688. PubMed ID: 30055941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
    Saito T; Kasamatsu A; Ogawara K; Miyamoto I; Saito K; Iyoda M; Suzuki T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
    PLoS One; 2015; 10(9):e0137923. PubMed ID: 26378920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Knockdown of PFTK1 inhibits tumor cell proliferation, invasion and epithelial-to-mesenchymal transition in pancreatic cancer.
    Zheng L; Zhou Z; He Z
    Int J Clin Exp Pathol; 2015; 8(11):14005-12. PubMed ID: 26823712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin.
    Kobayashi T; Shimura T; Yajima T; Kubo N; Araki K; Tsutsumi S; Suzuki H; Kuwano H; Raz A
    Int J Cancer; 2011 Dec; 129(12):2775-86. PubMed ID: 21448903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
    Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of CD44 in pancreatic cancer and its significance.
    Li XP; Zhang XW; Zheng LZ; Guo WJ
    Int J Clin Exp Pathol; 2015; 8(6):6724-31. PubMed ID: 26261555
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Schwann Cells Increase Prostate and Pancreatic Tumor Cell Invasion Using Laminin Binding A6 Integrin.
    Sroka IC; Chopra H; Das L; Gard JM; Nagle RB; Cress AE
    J Cell Biochem; 2016 Feb; 117(2):491-9. PubMed ID: 26239765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathways.
    Chen Q; Yang C; Chen L; Zhang JJ; Ge WL; Yuan H; Meng LD; Huang XM; Shen P; Miao Y; Jiang KR
    Br J Cancer; 2019 Nov; 121(11):912-921. PubMed ID: 31631174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GCN5 inhibition prevents IL-6-induced prostate cancer metastases through PI3K/PTEN/Akt signaling by inactivating Egr-1.
    Shao G; Liu Y; Ma T; Zhang L; Yuan M; Zhao S
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30333255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.